A regulatory gap: addressing visible particle control in cell and gene therapies through a risk-based framework

Digital Chinese Medicine · Elsevier

Аннотация

Publication date: December 2026 Source: Cytotherapy, Volume 28, Issue 12 Author(s): Antonio Scatena, Sarah Saietz, Sean Werner, David Stull, Christopher Harrison, Manufacturing Materials Safety & Technology Working Group (formerly the Particulate Working Group) Within the ISCT Process Development & Manufacturing Committee

Читать у издателя →

Похожие статьи